About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials in Massachusetts | 383 Studies

Clinical Trials Pancreatic CancerMassachusetts

Pancreatic Cancer Clinical Trials in Massachusetts

Find 383 clinical trials for pancreatic cancer near Massachusetts. Connect with research centers in your area.

All Pancreatic Cancer trials nationwide All trials in Massachusetts

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 21-40 of 383 trials

RecruitingTesting the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 GeneThis phase I trial tests the safety, side effects, and best dose of neratinib in combination with trastuzumab deruxtecan in treating patients with solid tumors that have spread…NCT05372614·Duarte, California and 17 others

Pancreatic Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingA Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103)The study aims to determine maximum tolerated dose (MTD) or recommended combination dose of the MTA-cooperative PRMT5 inhibitor Anvumetostat administered in combination with other…NCT06360354·Bakersfield, California and 76 others

TerminatedStudy of MRTX1133 in Patients With Advanced Solid Tumors Harboring a KRAS G12D MutationA Phase 1/2 study of MRTX1133 in solid tumors harboring a KRAS G12D mutation.NCT05737706·Phoenix, Arizona and 13 others

RecruitingTegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid TumorsThis phase I/II trial evaluates the highest safe dose, side effects, and possible benefits of tegavivint in treating patients with solid tumors that has come back (recurrent) or…NCT04851119·Birmingham, Alabama and 20 others

CompletedProspective Analysis of Hypersensitivity Reactions to OxaliplatinThis research study will examine how often hypersensitivity, or allergic reactions, occur in patients receiving the chemotherapy medication oxaliplatin.NCT00831571·Boston, Massachusetts

CompletedGenetic Testing for Breast, Ovarian, Pancreatic, and Prostate CancersThis study is evaluating the effect of two pre-test education methods on participants interested in genetic testing for hereditary cancer risk.NCT04330716·Boston, Massachusetts and 5 others

TerminatedA Study of SGN-STNV in Advanced Solid TumorsThis trial will look at a drug called SGN-STNV to find out whether it is safe for patients with solid tumors. It will study SGN-STNV to find out what its side effects are.NCT04665921·Los Angeles, California and 17 others

Active not recruitingA Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid TumorsThe main purpose of the study is to assess whether the study drug, LY4066434, is safe and tolerable when administered to participants with locally advanced or metastatic solid…NCT06607185·Birmingham, Alabama and 44 others

CompletedPembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid TumorsThis is an open-label, multicenter, Phase 1b platform study in subjects with advanced or metastatic solid tumors (Part 1a) and subjects with selected solid tumors (Part 1b and…NCT02646748·San Francisco, California and 16 others

TerminatedA Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid TumorsThis study will test the safety of a drug called PF-08046049/SGN-BB228 in participants with melanoma and other solid tumors that are hard to treat or have spread through the body.NCT05571839·Los Angeles, California and 36 others

WithdrawnA Pilot Study of BXCL701 in Patients With Pancreatic CancerA study to assess the biochemical and immunomodulatory effects of BXCL701 in pancreatic cancer.NCT04123574·Boston, Massachusetts and 1 other

CompletedSapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by SurgeryThis phase II trial studies how well sapanisertib works in treating patients with pancreatic neuroendocrine tumor that has spread to other places in the body (metastatic), does…NCT02893930·Phoenix, Arizona and 404 others

Active not recruitingSafety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCThis is a First-in-Human Phase IA/IB/II open label dose escalation study of intravenous (IV) administration of ONC-392, a humanized anti-CTLA4 IgG1 monoclonal antibody, as single…NCT04140526·Springdale, Arkansas and 36 others

Active not recruitingTesting Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid TumorsThis phase III trial studies cabozantinib to see how well it works compared with placebo in treating patients with neuroendocrine or carcinoid tumors that may have spread from…NCT03375320·Anchorage, Alaska and 431 others

TerminatedBinimetinib and Encorafenib for the Treatment of Pancreatic Cancer in Patients With a Somatic BRAF V600E MutationThis phase II trial studies the side effects and how well the combination of binimetinib and encorafenib work in treating patients with pancreatic cancer with a somatic BRAF V600E…NCT04390243·Phoenix, Arizona and 4 others

Active not recruitingAGEN1423 and Botensilimab w/ or w/o Chemo in PDACThe goal of this research study is to asses the safety and efficacy of the combination of AGEN1423 and Botensilimab with or without chemotherapies, gemcitabine and nab-paclitaxel…NCT05632328·Boston, Massachusetts

CompletedVideo Education With Result Dependent dIsclosureThe overall study objective of this trial study is to identify and evaluate strategies to improve the accessibility of the video education with result dependent disclosure (VERDI)…NCT05225428·Boston, Massachusetts

CompletedRadiation w/FOLFIRINOX-Losartan for Pancreatic CancerThis is a Phase II clinical trial, which tests the safety and effectiveness of an investigational combination of drugs to learn whether the combination of drugs works in treating…NCT01821729·Boston, Massachusetts

RecruitingStudy of RMC-9805 in Participants With KRAS G12D-Mutant Solid TumorsThis study is to evaluate the safety and tolerability of RMC-9805 as monotherapy and in combination with RMC-6236 in adults with KRAS G12D-mutant solid tumors.NCT06040541·Sacramento, California and 16 others

CompletedDoes Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?The purpose of this study is to figure out which commonly used antibiotic, cefoxitin or piperacillin-tazobactam, is better at decreasing the rate of surgical site infections after…NCT03269994·Sacramento, California and 31 others

PreviousPage 2 of 20Next

Other Conditions in Massachusetts

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia